Anterior Ischemic Optic Neuropathy

Slide 1 · Anterior Ischemic Optic Neuropathy

Pathogenesis • Morphology • Diagnostic reasoning

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain optic nerve ischemia as a continuum from transient dysfunction to infarction.

Distinguish arteritic AION, particularly giant cell arteritis, from nonarteritic AION.

Interpret optic disc edema, visual field findings, and key differential diagnoses.

Prioritize urgent evaluation when ischemic visual loss may threaten the fellow eye.

Slide 3 · What does AION mean?

Anterior

The injury primarily involves the optic nerve head or immediately adjacent optic nerve.

Ischemic

Reduced or interrupted perfusion compromises axonal function and viability.

Optic neuropathy

Visual dysfunction arises from injury to the optic nerve rather than only the ocular media.

Slide 4 · The optic nerve is a CNS tract

Retinal ganglion cell axons converge at the optic nerve head and carry visual information centrally.

The nerve has meningeal coverings and is surrounded by cerebrospinal fluid.

Its response to infarction resembles other central nervous system tissue: Lost axons do not regenerate.

These anatomical properties also explain why raised intracranial pressure can cause disc swelling.

Slide 5 · From retinal ganglion cells to optic nerve

Retinal ganglion cells

Generate axons within the retinal nerve fiber layer.

→

Optic disc

Axons converge and leave the eye at the optic nerve head.

→

Optic nerve

Carries visual signaling toward intracranial visual pathways.

Conceptual anatomical sequence; Not a scaled illustration.

Slide 6 · Anterior optic nerve perfusion: Conceptual map

Arterial inflow

Posterior ciliary circulation contributes to optic nerve head perfusion.

→

Capillary exchange

Tissue oxygen delivery supports optic nerve axonal function.

→

Axonal integrity

Ischemia threatens signal conduction and, when prolonged, tissue survival.

Slide 7 · Ischemia and infarction are not synonymous

Ischemia

Perfusion is insufficient for normal neural function.

Axons may remain viable despite visual dysfunction.

Recovery is possible if blood flow and tissue viability are preserved.

Infarction

Prolonged or severe perfusion failure causes irreversible tissue injury.

Optic nerve axons are lost.

Visual loss attributable to the infarct is permanent.

Slide 8 · Transient perfusion interruption

Brief flow reduction

Temporary failure to deliver sufficient oxygen.

→

Reversible dysfunction

Visual disturbance may occur without established infarction.

→

Flow restoration

Function can recover if the tissue remains viable.

Slide 9 · Complete perfusion interruption

Critical flow loss

Sustained deprivation of optic nerve tissue.

→

Optic nerve infarct

Irreversible ischemic axonal injury.

→

Persistent visual deficit

Lost neural tissue cannot regenerate.

Slide 10 · Why the deficit may be segmental

Infarct core

Some optic nerve sectors may sustain irreversible infarction.

Bordering ischemic tissue

Adjacent poorly perfused tissue may remain viable.

Partial recovery

Improvement does not require regeneration of dead axons; Surviving tissue can recover function.

Slide 11 · Viable ischemia versus established tissue death

Poor perfusion + viability

Functional impairment may be substantial.

The ischemic region can survive.

Improvement is biologically possible.

Irreversible axonal injury

There has been loss of neuronal structure.

Resolution of swelling does not restore destroyed axons.

Residual visual loss is permanent.

Slide 12 · The stroke analogy: Useful but incomplete

Both stroke and AION represent vascular injury to nervous tissue.

Interruption may be transient, segmental, or sufficiently complete to cause infarction.

CNS tissue survival, not merely the degree of visible edema, determines irreversibility.

An optic disc appearance alone does not identify the precise vascular mechanism.

Slide 13 · Three routes to perfusion failure

Vasculitis

Inflammation of feeding arteries can compromise the lumen and flow.

Thrombus

In-situ clot formation may obstruct vascular supply.

Embolus

An intravascular embolic event may interrupt upstream delivery.

Slide 14 · Inflammatory arterial injury

Arterial inflammation

Vessel-wall pathology develops.

→

Reduced effective lumen

Arterial supply to the nerve falls.

→

Optic nerve ischemia

Visual dysfunction can progress to infarction.

Slide 15 · Thrombotic interruption

Intracirculatory clot

Thrombus can obstruct a supplying vessel.

→

Reduced downstream flow

Hypoperfusion develops in dependent tissue.

→

Ischemic optic neuropathy

Severity depends on extent and persistence of ischemia.

Slide 16 · Embolic interruption

Mobile intravascular material

Embolic material can obstruct flow.

→

Acute perfusion defect

Previously perfused tissue receives less blood.

→

Variable neural injury

Transient dysfunction or infarction depends on tissue viability.

Slide 17 · Pale swollen disc: The Robbins visual clue

Schematic — not a clinical specimen

The optic nerve head may be swollen in acute AION.

Relative pallor reflects decreased optic nerve perfusion.

Pallor is a clue to ischemia, not a stand-alone etiologic diagnosis.

Slide 18 · Two major clinical forms

Arteritic AION (AAION)

Typically linked to giant cell arteritis in older adults; A vision-threatening emergency.

Nonarteritic AION (NAION)

Usually presents as acute optic nerve head ischemia without a systemic arteritis.

Shared phenotype

Disc edema and sudden optic nerve dysfunction can occur in both forms.

Slide 19 · Arteritic AION: Why it matters

Giant cell arteritis can cause ischemic injury of the optic nerve head.

Visual loss may be severe and irreversible.

The second eye can become involved rapidly if active arteritis remains untreated.

Diagnosis and treatment are time-critical when giant cell arteritis is suspected.

Slide 20 · Giant cell arteritis: Tissue-to-vision pathway

Arterial wall inflammation

Inflammatory disease affects medium and large arteries.

→

Luminal compromise

The posterior ciliary circulation may be reduced or occluded.

→

Optic nerve infarction

Severe anterior optic nerve ischemia causes persistent loss of vision.

Slide 21 · Giant cell arteritis: Arterial histopathology

The affected vessel may show panarterial inflammatory infiltrates.

Intimal thickening can restrict the lumen and impair perfusion.

Fragmentation of the internal elastic lamina is an important morphologic clue.

Multinucleated giant cells may be present but are not required in every biopsy.

Slide 22 · Why arteritic disease creates a pale disc

Inflamed feeding artery

Severe perfusion deficit can affect the optic nerve head.

→

Ischemic edema

Swelling coexists with diminished tissue perfusion.

→

Pallid disc

A chalky-white appearance raises concern for AAION.

Slide 23 · Giant cell arteritis: Systemic red flags

New headache, particularly temporal, or scalp tenderness.

Jaw claudication or tongue claudication.

Constitutional symptoms such as fatigue, fever, or weight loss.

Shoulder or pelvic-girdle symptoms compatible with polymyalgia rheumatica.

Absence of typical systemic symptoms does not reliably exclude the disease.

Slide 24 · Preceding visual symptoms are warning signs

Transient monocular visual loss may herald major visual injury.

Diplopia and other ocular ischemic symptoms may precede established infarction.

A history of brief episodes is not reassuring when giant cell arteritis is possible.

Urgency is determined by clinical suspicion, not by whether the symptoms have resolved.

Slide 25 · The arteritic optic disc phenotype

Schematic — not a clinical specimen

Often pronounced, diffuse, pallid disc swelling.

A relative afferent pupillary defect is expected with unilateral severe optic neuropathy.

Concurrent retinal ischemic findings strengthen suspicion for severe arterial disease.

Overlap with nonarteritic AION limits specificity.

Slide 26 · Potential consequences of untreated arteritis

First eye

Optic nerve infarction can produce permanent visual loss.

Fellow eye

Further ischemic loss may develop within days in active disease.

Clinical aim

Urgent therapy chiefly aims to prevent additional ischemic damage.

Slide 27 · Suspected giant cell arteritis: Urgent sequence

Recognize

Older patient, acute visual loss, disc edema, compatible symptoms.

↓

Evaluate urgently

Ophthalmic assessment plus inflammatory markers and vascular testing.

↓

Treat immediately

Start physician-directed glucocorticoids when clinical suspicion is high.

↓

Confirm diagnosis

Arrange temporal artery assessment without delaying therapy.

Slide 28 · Inflammatory markers support—but do not define—GCA

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) support assessment.

Platelet count and other findings may add evidence of systemic inflammation.

No single blood test establishes or excludes giant cell arteritis.

Interpret laboratory data alongside the history, disc examination, and vascular studies.

Slide 29 · A positive result and a negative result have different limits

Raised ESR / CRP

May support the presence of inflammation.

Not specific for giant cell arteritis.

Cannot prove the vascular cause of disc edema alone.

Normal ESR / CRP

Do not reliably exclude giant cell arteritis.

Especially hazardous if used to dismiss a classic ischemic presentation.

High clinical suspicion still requires action.

Slide 30 · Temporal artery biopsy: What pathology seeks

Inflammatory infiltrates within the vessel wall.

Intimal hyperplasia and possible luminal narrowing.

Fragmentation of the internal elastic lamina.

Granulomatous inflammation and multinucleated giant cells when present.

Slide 31 · Why biopsy can miss giant cell arteritis

Segmental disease

Inflammation may occur in discontinuous “skip lesions”.

→

Sampling limitation

A sampled segment may not contain diseased artery.

→

Clinical integration

A negative biopsy is not an absolute exclusion.

Slide 32 · Imaging and tissue sampling are complementary

Temporal artery biopsy provides histopathologic evidence of arteritis.

Vascular ultrasound can identify arterial wall changes when expertise is available.

Additional noninvasive vascular imaging may be useful when biopsy is negative but suspicion persists.

Preferred first-line testing differs by guideline and local access; The clinical emergency remains unchanged.

Slide 33 · Treat first when sight is threatened

Immediate priority

Urgent assessment and glucocorticoids for suspected GCA.

Protect the affected and unaffected eye from further ischemic injury.

Do not await confirmatory biopsy to start treatment.

Subsequent priorities

Obtain pathologic/vascular confirmation.

Assess systemic disease involvement.

Plan individualized treatment and toxicity monitoring.

Slide 34 · GCA with threatened vision: Guideline nuance

The 2021 ACR/VF guideline conditionally favors pulse intravenous glucocorticoids over high-dose oral therapy.

Supporting evidence is low certainty; Treatment depends on clinical context and toxicity considerations.

The urgent principle remains immediate glucocorticoid treatment when GCA is strongly suspected.

This lecture does not prescribe an individual dose or regimen.

Slide 35 · What treatment can and cannot accomplish

Prevent extension

Suppressing arteritis reduces risk of additional ischemic events.

Lost axons

Established optic nerve infarction is not reversed by regeneration.

Follow-up

Longitudinal vascular, ocular, and treatment-toxicity surveillance remains necessary.

Slide 36 · Nonarteritic AION: Core phenotype

Acute ischemic optic nerve injury without underlying giant cell arteritis.

Usually acute, painless, monocular visual loss.

An edematous optic disc accompanies the acute event.

The diagnosis is mainly clinical and requires exclusion of masquerading disorders.

Slide 37 · NAION: A perfusion–susceptibility interaction

Predisposed disc

A small, crowded optic nerve head can increase vulnerability.

→

Perfusion disturbance

Reduced microvascular supply impairs axonal function.

→

Secondary swelling

Disc edema develops and may amplify tissue crowding.

Slide 38 · The “disc at risk” concept

Schematic — not a clinical specimen

The fellow optic disc may be small and physiologically crowded.

A small cup provides less reserve space for axonal swelling.

Disc configuration is a risk association, not a diagnostic test.

Not every patient with a crowded disc develops NAION.

Slide 39 · Systemic associations of NAION

Hypertension and diabetes mellitus are commonly associated.

Dyslipidemia, smoking, and other vascular risks may contribute.

Obstructive sleep apnea is a clinically relevant association.

Associations do not establish one uniform thrombotic or embolic cause.

Slide 40 · The usual clinical presentation of NAION

Sudden or rapidly noticed reduction of vision, typically in one eye.

The episode is classically painless.

Decreased visual acuity and/or visual field loss may dominate.

Optic disc edema is present acutely, with sectoral or diffuse involvement.

Slide 41 · What a relative afferent pupillary defect means

An afferent pupillary defect suggests asymmetric optic nerve dysfunction.

It is commonly present when one eye has more substantial ischemic injury.

The finding localizes dysfunction but does not establish an arteritic versus nonarteritic cause.

It should be interpreted alongside acuity, fields, and the disc.

Slide 42 · Altitudinal visual field loss

Schematic field loss

AION can produce superior or inferior altitudinal field defects.

The defect reflects the pattern of dysfunctional optic nerve fibers.

An altitudinal pattern is suggestive, not pathognomonic, for AION.

The shown field is schematic—not measured perimetry.

Slide 43 · NAION: Acute disc appearance

Schematic — not a clinical specimen

Sectoral or diffuse swelling may be normal-colored or hyperemic.

Peripapillary flame-shaped hemorrhages may occur.

Pallid edema can also occur, so color is not absolute.

Assess systemic arteritic clues before assigning a nonarteritic label.

Slide 44 · Disc hemorrhages: Useful but not decisive

Possible in NAION

Acutely swollen disc can show peripapillary hemorrhages.

Often accompanies sectoral disc edema.

Can coexist with variable loss of acuity.

Not exclusive

Other optic disc/retinal disorders also bleed.

AAION may have hemorrhage as well.

Morphology must be integrated with history and testing.

Slide 45 · Optic disc evolution after NAION

Acute phase

Swelling of the optic nerve head and visual dysfunction.

→

Resolution

Edema diminishes over subsequent weeks.

→

Chronic phase

Optic disc pallor and nerve-fiber loss reveal residual damage.

Slide 46 · OCT findings evolve with time

During acute edema

Retinal nerve fiber layer thickness may rise from swelling.

Thickness alone does not quantify viable axons.

Interpret scans in relation to disc examination.

After swelling resolves

RNFL and ganglion cell thinning can reflect axonal loss.

Structural atrophy helps document chronic injury.

Visual function may remain impaired.

Slide 47 · NAION: A diagnosis made by clinical integration

History: Temporal profile and painlessness of vision loss.

Examination: Acuity, color vision, pupils, visual fields, and optic disc.

Laboratory exclusion of giant cell arteritis when clinically indicated.

Neuroimaging or additional studies for atypical presentations or competing diagnoses.

Slide 48 · NAION: Treatment evidence and counseling

There is no established treatment that reliably reverses visual loss from NAION.

Disc edema commonly resolves even when deficits persist.

Address associated vascular and sleep-related conditions as clinically appropriate.

Explain residual loss and the need to protect function in the fellow eye.

Slide 49 · Fellow-eye care after NAION

A second-eye event is possible; Follow-up should not focus exclusively on the first eye.

Review blood pressure, glycemic control, lipid status, smoking, and sleep apnea.

Aspirin has not been proven to prevent second-eye NAION.

Prevention discussions should avoid presenting observational associations as established interventions.

Slide 50 · Arteritic versus nonarteritic AION

Feature

Arteritic AION

Nonarteritic AION

Systemic process

Often giant cell arteritis

No systemic arteritis by definition

Visual loss

Frequently profound

Severity variable

Disc

Often marked pallid edema

Frequently segmental, normal-colored or hyperemic edema

Associated clues

Headache, jaw claudication, systemic symptoms

Crowded disc, vascular risk associations

Immediate priority

Urgent glucocorticoids when GCA suspected

Exclude GCA; optimize associated risks

Slide 51 · Optic neuropathy: Pattern recognition

Disorder

Typical mechanism

Clue to distinguish

AION

Ischemic optic nerve injury

Acute visual deficit + disc edema

Papilledema

Raised CSF pressure → axoplasmic stasis

Usually bilateral disc swelling; may preserve early acuity

Glaucoma

Chronic optic nerve damage

Optic disc cupping/atrophy and field loss

Optic neuritis

Usually demyelinating optic nerve dysfunction

Different clinical course; brain lesions can suggest MS

Slide 52 · Papilledema: A pressure-mediated mechanism

Increased CSF pressure

Meningeal CSF encircles the optic nerve.

→

Impeded transport

Venous stasis and axoplasmic flow disturbance occur.

→

Disc swelling

Optic nerve head becomes swollen and hyperemic.

Slide 53 · Papilledema: Hyperemia versus AION pallor

Schematic — not a clinical specimen

Papilledema from elevated intracranial pressure is commonly bilateral.

Acutely the disc is swollen and hyperemic.

Early central acuity is often preserved.

Compare with the relatively pale ischemic disc in the Robbins illustration.

Slide 54 · Disc swelling is not the same as infarction

AION

Perfusion is reduced in affected optic nerve tissue.

Vision may be impaired at presentation.

Infarction causes irreversible axonal loss.

Papilledema

Raised intracranial pressure interferes with axoplasmic transport.

Early visual loss may be absent.

Persistent swelling also demands urgent evaluation of its cause.

Slide 55 · Glaucoma versus AION

Glaucoma

Often a chronic process with optic disc cupping.

Retinal ganglion cell loss and RNFL thinning.

Disc edema is not the classic chronic morphology.

AION

Acute ischemic injury may present with disc edema.

Pallor can follow atrophy after the acute phase.

Presentation and mechanism differ from chronic glaucoma.

Slide 56 · Optic neuritis versus AION

Optic neuritis

In routine usage, often demyelinating optic neuropathy.

Multiple sclerosis is an important association.

Some patients recover visual function.

AION

Predominant mechanism is impaired blood delivery.

Infarcted optic nerve tissue does not regenerate.

GCA must be excluded in the appropriate patient.

Slide 57 · Reason through sudden monocular visual loss

Establish localization

Acuity, visual field, pupils, optic disc and retina.

↓

Identify emergencies

Possible GCA, retinal vascular occlusion, other acute pathology.

↓

Select investigations

Inflammatory testing, ocular assessment, targeted imaging.

↓

Act on threat

Do not delay treatment for strongly suspected GCA.

Slide 58 · Triage priorities when AION is suspected

Determine onset, progression, laterality, and associated pain.

Ask immediately about headache, jaw claudication, scalp tenderness, systemic symptoms, and transient loss.

Examine optic disc, pupils, acuity, visual fields, and both eyes.

Arrange same-day specialist/emergency assessment when giant cell arteritis is possible.

Slide 59 · Case 1: Abrupt severe loss and headache

Clinical vignette

An older adult reports abrupt monocular visual loss, new temporal headache, and jaw fatigue during chewing. The affected optic disc is markedly pale and swollen.

Discussion prompts

What immediately dangerous diagnosis must be excluded?

Should treatment wait for a temporal artery biopsy?

Slide 60 · Case 2: A crowded fellow disc

Clinical vignette

A patient notices painless monocular visual loss on waking. The optic disc is swollen, the field has an inferior defect, and the unaffected disc has a small physiologic cup.

Discussion prompts

Which diagnosis fits this pattern?

Why must an arteritic process still be considered when clinically appropriate?

Slide 61 · Case 3: Swelling without early acuity loss

Clinical vignette

A patient has bilateral hyperemic optic disc swelling. Central visual acuity remains preserved and a raised cerebrospinal fluid pressure mechanism is suspected.

Discussion prompts

Which alternative diagnosis is central?

What is the principal mechanism of disc swelling?

Slide 62 · Case 4: Transient visual blackout

Clinical vignette

A patient describes a brief episode of monocular visual loss that resolved. There is no persistent deficit at the time of examination.

Discussion prompts

Does resolution rule out ischemia?

What changes when arteritis is suspected?

Slide 63 · Four common reasoning errors

Assuming every swollen disc represents increased intracranial pressure.

Using a normal inflammatory marker result to exclude giant cell arteritis.

Interpreting resolution of disc edema as proof of axonal recovery.

Equating a crowded disc or altitudinal defect with definitive NAION.

Slide 64 · Clinicopathologic synthesis

AION is an ischemic continuum: Transient dysfunction, segmental injury, or optic nerve infarction.

Permanent visual loss reflects lost CNS axons; Partially ischemic viable tissue can recover.

Pale swollen disc suggests hypoperfusion, but clinical context distinguishes mechanisms.

Giant cell arteritis requires immediate recognition because additional vision loss may be preventable.

Slide 65 · References and source boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 29: The Eye.

American Academy of Ophthalmology EyeWiki: NAION, AAION, and Giant Cell Arteritis.

American College of Rheumatology/Vasculitis Foundation guideline for GCA (2021).

North American Neuro-Ophthalmology Society: NAION patient education (2023).

All optic disc and visual field illustrations in this lecture are original schematics, not patient specimens.